Dr. Ahmaida Zeglam, MD

Dr. Zeglam practices at Laser and Outpatient Surgery Center - Gainesville in Gainesville, Florida.

Dr. Zeglam's NPI, 1518386762, was assigned on April 15, 2014. Dr. Zeglam graduated from University of Arkansas For Medical Sciences College of Medicine in 2014. Dr. Zeglam holds Florida license ME136033.

Dr. Zeglam's primary practice is Laser and Outpatient Surgery Center - Gainesville, at 6925 Nw 11th Place, Gainesville, FL 32606. The practice phone is (352) 373-9140.

Dr. Zeglam's primary practice is Laser and Outpatient Surgery Center - Gainesville in Gainesville, Florida. Dr. Zeglam is also affiliated with UF Health Shands Hospital. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Zeglam to 1 more group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zeglam practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Zeglam's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Zeglam is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Zeglam is licensed in Florida.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, cold sores or genital herpes, conjunctivitis, dry eye, eye infection or inflammation and eyelid inflammation among the conditions Dr. Zeglam treats.

CMS data shows 7,285 Medicare services from Dr. Zeglam across 13 procedure codes in 2024, for 2,532 Medicare patients. Medicare paid $555,629 for them.

CMS counts 2,532 Medicare patients who saw Dr. Zeglam in 2024. The largest group is 75 to 84, with 1,113 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.07, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Zeglam's median patient age at 74, with 62% women.

In 2024, Dr. Zeglam wrote 4,741 Medicare Part D claims for 1,041 patients. 74% of them were for generic drugs. CMS names the drug for 4,648 of them, across 24 drugs with 11 or more claims each, at $249,963 in total drug cost. In 2023, CMS named 4,081 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Zeglam for performance year 2024, reported as part of a group. Dr. Zeglam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 488 procedures of cataract surgery by Dr. Zeglam, more than 95% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Zeglam in 2020. The most frequent topics are Diagnosis, Differential and Tomography, X-Ray Computed. Dr. Zeglam has published most often in Ophthalmic Plast Reconstr Surg. Dr. Zeglam's most frequent co-authors are John D. Pemberton, DO, Ansuya Prithavi Deosaran, MD and Peter William Macintosh, MD.

CMS Open Payments shows 224 general payments to Dr. Zeglam from 28 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Alcon Laboratories Inc paid the most, $2,331.

Dmand AI lists 1 award for Dr. Zeglam.

Dr. Zeglam graduated from University of Arkansas For Medical Sciences College of Medicine in 2014. Dr. Zeglam is a member of AOA, AAO, ASCRS and Florida Medical Association.

Dr. Zeglam is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.